Invention Grant
- Patent Title: Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
-
Application No.: US17186447Application Date: 2021-02-26
-
Publication No.: US11718641B2Publication Date: 2023-08-08
- Inventor: Guoqiang Wang , Yat Sun Or , Ruichao Shen , Jiang Long , Peng Dai , Xuechao Xing , Jing He
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07J41/00
- IPC: C07J41/00 ; C07J43/00 ; C07J9/00 ; C07J51/00
Abstract:
The present invention provides compounds of Formula I,
pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Public/Granted literature
- US20210261600A1 Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof Public/Granted day:2021-08-26
Information query
